Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Ok over the last 4 -not really
Reply New Message
Back To Forum List View
Ok over the last 4 -Quaters Cash/cash equvalents has improved!!!!
2
paylslyone
May 07, 2010 11:48AM

I believe a lot of the gain in cash and cash equivalents is a result of the the conversion of marketable securities (the ARS) to cash. Just changing columns on the sheet.

Some other observations from the 10Q

Shareholders equity down

Total stockholders’ equity
 24,272,314 29,650,891
Total liabilities and stockholders’ equity
 $ 28,077,620 $ 33,726,95

Operating loss unchanged

Operating loss
 (1,521,431 ) (1,643,332 ) (11,263,653 ) (4,330,617
Re: Ok over the last 4 -not really..sedley..let me put this into context..
4
paylslyone
May 07, 2010 12:19PM
BTW (and I defer to Fut in these matters) so I may be wrong

Sedley
May 07, 2010 12:21PM
Re: BTW (and I defer to Fut in these matters) so I may be wrong...Sed
6
FutTheWuk
May 07, 2010 12:43PM
Thanks Fut - but I also believe that I'm on the right track
1
Sedley
May 07, 2010 01:45PM
Re: Thanks Fut - but I also believe that I'm on the right track
1
FutTheWuk
May 07, 2010 02:25PM
Re: Thanks Fut - but I also believe that I'm on the right track
2
GKRichard
May 07, 2010 02:30PM
Re: Thanks Fut - but I also believe that I'm on the right track
3
optymystic
May 07, 2010 02:57PM
Re: Thanks Fut - but I also believe that I'm on the right track
1
GKRichard
May 07, 2010 03:08PM
Re: Thanks Fut - but I also believe that I'm on the right track
3
optymystic
May 07, 2010 04:06PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply